HIV testing market to rise with increasing awareness
December 1 is World’s AIDS day. A day to recognize and address the ongoing disparities related to Human Immunodeficiency
Virus (HIV) and acquired immunodeficiency syndrome (AIDS). This year the World Health Organization (WHO) has partnered with
World AIDS day to highlight the inequalities that are restricting ending the HIV pandemic. This global health day aims to equalize
vital HIV services to the most at-risk populations and destigmatize HIV/AIDs through education. According to UNAIDS, in 2021,
there were 38.4 million people globally living with HIV and 1.5 million were newly infected. In GlobalData’s HIV tests market model
indicates that more than 538 million HIV tests were sold globally in 2021 and almost 540 million will be sold in 2030*. GlobalData predicts
that the global HIV test market will reach $2.3bn by 2030* growing at a CAGR of 1.5%.
The Covid-19 pandemic normalized frequent disease testing. People are becoming more proactive in monitoring their health, particularly
in infectious diseases. This testing momentum coupled with increased HIV awareness and education will push people to get tested more frequently.
Mandelab have been devoted our production and service for the Covid-19 testing in the past 3years, and we will keep moving on providing
related sterile sampling swabs for the other diagnostic requirement, especially HIV testing. We have our own 600sqm equipped laboratory,
3500sqm GMP work shop, completed certification, and R&D department, which ensure us will make the fastest reaction for the demand of
most diagnostic companies, to produce any sterile sampling swabs they want.
